Comparison of the involvement of protein kinase C in agonist-induced contractions in mouse aorta and corpus cavernosum

European Journal of Pharmacology

Volumn 590, Issue 1-3, 2008, Pages 363-368

  Jin, Liming ^a   Teixeira, Cleber E ^b   Webb, R Clinton ^b   Leite, Romulo ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Erectile dysfunction; Erectile function; Erection; Penis; Protein kinase C; Smooth muscle

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BETA ACTIN; CHELERYTHRINE; PHENYLEPHRINE; PHORBOL DIBUTYRATE; POTASSIUM CHLORIDE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C ALPHA; PROTEIN KINASE C ALPHA INHIBITOR; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA INHIBITOR; PROTEIN KINASE C INHIBITOR; THROMBOXANE RECEPTOR STIMULATING AGENT;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG SELECTIVITY; MALE; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE CONTRACTION; VASCULAR RING; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; AORTA; BENZOPHENANTHRIDINES; CALCIUM; MALE; MICE; MUSCLE CONTRACTION; NG-NITROARGININE METHYL ESTER; PENIS; PHENYLEPHRINE; PROTEIN KINASE C; VASOCONSTRICTION;

EID: 48049118793     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.06.001     Document Type: Article

References (23)

1. Andersson K.E., and Wagner G. Physiology of penile erection. Physiol. Rev. 75 (1995) 191-236
2. Angulo J., Cuevas P., Fernandez A., Allona A., Moncada I., Martin-Morales A., La Fuente J.M., and de Tejada I.S. Enhanced thromboxane receptor-mediated responses and impaired endothelium-dependent relaxation in human corpus cavernosum from diabetic impotent men: role of protein kinase C activity. J. Pharmacol. Exp. Ther. 319 (2006) 783-789
3. Bilder G.E., Kasiewski C.J., and Perrone M.H. Phorbol-12,13-dibutyrate-induced vasoconstriction in vivo: characterization of response in genetic hypertension. J. Pharmacol. Exp. Ther. 252 (1990) 526-530
4. Budzyn K., Paull M., Marley P.D., and Sobey C.G. Segmental differences in the roles of Rho-kinase and protein kinase C in mediating vasoconstriction. J. Pharmacol. Exp. Ther. 317 (2006) 791-796
5. Burnett A.L. General use of animal models for investigation of the physiology of erection. Int. J. Impot. Res. 13 (2001) 135-139
6. Disanto M.E. Contractile mechanisms in diabetes-related erectile dysfunction. Curr. Pharm. Des. 11 (2005) 3995-4010
7. Giuliano F. Rodents in impotence research: functional and genetic aspects. Int. J. Impot. Res. 13 (2001) 143-145
8. Holmquist F., Andersson K.E., and Hedlund H. Actions of endothelin on isolated corpus cavernosum from rabbit and man. Acta Physiol. Scand. 139 (1990) 113-122
9. Husain S., Young D., and Wingard C.J. Role of PKCalpha and PKCiota in phenylephrine-induced contraction of rat corpora cavernosa. Int. J. Impot. Res. 16 (2004) 325-333
10. Jiang M.J., Chan C.F., and Chang Y.L. Intracellular calcium and myosin light chain phosphorylation during U46619-activated vascular contraction. Life Sci. 54 (1994) 2005-2013
11. Jin L., and Burnett A.L. RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights. Clin. Sci. (Lond.) 110 (2006) 153-165
12. Jin L., Liu T., Lagoda G.A., Champion H.C., Bivalacqua T.J., and Burnett A.L. Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction. FASEB J. 20 (2006) 536-538
13. Merkel L.A., Rivera L.M., Colussi D.J., and Perrone M.H. Protein kinase C and vascular smooth muscle contractility: effects of inhibitors and down-regulation. J. Pharmacol. Exp. Ther. 257 (1991) 134-140
14. Nangle M.R., Cotter M.A., and Cameron N.E. Protein kinase C beta inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic mice. Eur. J. Pharmacol. 475 (2003) 99-106
15. Salamanca D.A., and Khalil R.A. Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension. Biochem. Pharmacol. 70 (2005) 1537-1547
16. 2+ sensitivity in rat tail artery. J. Cardiovasc. Pharmacol. 38 (2001) 347-355
17. Shima H., and Blaustein M.P. Contrasting effects of phorbol esters on serotonin- and vasopressin-evoked contractions in rat aorta and small mesenteric artery. Circ. Res. 70 (1992) 978-990
18. Somlyo A.P., and Somlyo A.V. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: 0modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83 (2003) 1325-1358
19. Suzuki S., Takata Y., Kubota S., Ozaki S., and Kato H. Characterization of the alpha-1 adrenoceptors in the mesenteric vasculature from deoxycorticosterone-salt hypertensive rats: studies on vasoconstriction, radioligand binding and postreceptor events. J. Pharmacol. Exp. Ther. 268 (1994) 576-583
20. Turla M.B., and Webb R.C. Enhanced vascular reactivity to protein kinase C activators in genetically hypertensive rats. Hypertension 9 (1987) 150-154
21. Turla M.B., and Webb R.C. Vascular responsiveness to protein kinase C activators in mineralocorticoid-hypertensive rats. J. Hypertens. 9 (1991) 209-215
22. White R.E., and Carrier G.O. Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin-diabetes. J. Pharmacol. Exp. Ther. 253 (1990) 1057-1062
23. Wier W.G., and Morgan K.G. Alpha1-adrenergic signaling mechanisms in contraction of resistance arteries. Rev. Physiol. Biochem. Pharmacol. 150 (2003) 91-139